{"id":"shr-1316-carboplatin-etoposide-radiotherapy","safety":{"commonSideEffects":[{"rate":"20-50%","effect":"Myelosuppression"},{"rate":"30-60%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Neutropenia"},{"rate":"10-30%","effect":"Thrombocytopenia"},{"rate":"10-20%","effect":"Anemia"}]},"_chembl":{"chemblId":"CHEMBL1351","moleculeType":"Small molecule","molecularWeight":"371.25"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Etoposide is a topoisomerase inhibitor that works by stabilizing the cleavage complex of DNA, thereby preventing DNA replication and transcription. Radiotherapy is a form of cancer treatment that uses high-energy radiation to kill cancer cells.","oneSentence":"Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell growth and inducing apoptosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:25.759Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Small cell lung cancer"},{"name":"Non-small cell lung cancer"},{"name":"Ovarian cancer"},{"name":"Testicular cancer"},{"name":"Other cancers"}]},"trialDetails":[{"nctId":"NCT06483282","phase":"PHASE2","title":"A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Jin Ying","startDate":"2024-06-21","conditions":"Small Cell Lung Cancer Limited Stage","enrollment":38},{"nctId":"NCT04562337","phase":"PHASE2","title":"SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2020-10-01","conditions":"Extensive-stage Small Cell Lung Cancer","enrollment":67},{"nctId":"NCT06478264","phase":"PHASE2","title":"A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Zhangzhou Municipal Hospital","startDate":"2024-07-13","conditions":"Esophageal Small Cell Carcinoma","enrollment":40},{"nctId":"NCT06424899","phase":"PHASE2","title":"A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC","status":"RECRUITING","sponsor":"Zeng Jian","startDate":"2024-05-19","conditions":"Non Small Cell Lung Cancer","enrollment":92},{"nctId":"NCT04691063","phase":"PHASE3","title":"The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-01-22","conditions":"Small-cell Lung Cancer","enrollment":486}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SHR-1316; Carboplatin; Etoposide；Radiotherapy","genericName":"SHR-1316; Carboplatin; Etoposide；Radiotherapy","companyName":"Jiangsu HengRui Medicine Co., Ltd.","companyId":"jiangsu-hengrui-medicine-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell growth and inducing apoptosis. Used for Small cell lung cancer, Non-small cell lung cancer, Ovarian cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}